Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) contractors at the Department of Health and Human Services
- Latest 12 months
- $1.8B
- Net obligations · Up $30.8M vs. $1.7B preceding
- Prime contractors
- 233
- With positive obligations in the latest 12 months
Market snapshot for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services
Federal records show $9.6B in net obligations across 2,573 awards in Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services from Oct 1, 2021 through Jul 27, 2026. This market accounts for 6.9% of $140.6B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 1.8% from $1.7B to $1.8B. 27 prime contractors accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY26 is year-to-date through Jul 27, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $2.1B | 1,871 | Complete |
| FY2023 | $3.1B | 1,814 | Complete |
| FY2024 | $2.2B | 2,036 | Complete |
| FY2025 | $1.4B | 1,765 | Complete |
| FY2026 | $837.5M | 899 | YTD through Jul 27, 2026 |
Market at a glance
All reported prime contract awards- All-period net obligations
- $9.6B
- 2,573 awards · 798 prime contractors
- Latest 12-month movement
- +1.8%
- $1.8B vs. $1.7B
- Leading eight prime share
- 66.9%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 6.9% of $140.6B in agency-wide net obligations.
- Set-aside share when reported
- 29.2% of 1,333 awards with reported set-aside status.
- Set-aside reporting
- 389 set aside · 944 no set-aside · 1,240 not reported
What changed in the last 12 months?
Jul 28, 2025–Jul 27, 2026, compared with Jul 28, 2024–Jul 27, 2025.
Competitive shifts
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION climbed the most in the contractor rankings
Market structure
Top-five contractor share increased
Award activity
LEIDOS BIOMEDICAL RESEARCH INC received an unusually large obligation action
Buyer demand
Reported obligations through NATIONAL INSTITUTES OF HEALTH NIAID increased
Reported obligations through NIH NCI decreased
View 5 additional material changes
Competitive shifts
NATIONAL JEWISH HEALTH fell the most in the contractor rankings
20 contractors were first observed in this market during the latest 12 months
View 20 contractors
- TEMPUS AI, INCFirst observed Sep 17, 2025 in this market$12.6M
- THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIOFirst observed Apr 22, 2026 in this market$9.4M
- ROCHESTER INSTITUTE OF TECHNOLOGYFirst observed Sep 30, 2025 in this market$4.5M
- APPILI THERAPEUTICS USA INC.First observed Sep 30, 2025 in this market$3.6M
- SIBEL HEALTH INC.First observed Feb 23, 2026 in this market$3.5M
- CONTINUITY BIOSCIENCES, LLCFirst observed Aug 22, 2025 in this market$3.0M
- CONSOLIDATED SAFETY SERVICES INCORPORATEDFirst observed Sep 22, 2025 in this market$1.1M
- HALCYON BIOMEDICAL INCFirst observed Feb 25, 2026 in this market$600K
- NIRSENSE, INCFirst observed Feb 27, 2026 in this market$600K
- GT BIOSCIENCES, INC.First observed Feb 25, 2026 in this market$600K
- L2 DIAGNOSTICS LLCFirst observed Jul 28, 2025 in this market$599K
- ZENSO INCFirst observed Feb 26, 2026 in this market$599K
- ALETHIUM TECHNOLOGIES, INC.First observed Feb 25, 2026 in this market$598K
- RENSSELAER POLYTECHNIC INSTITUTEFirst observed Sep 26, 2025 in this market$362K
- SYZONC, INCFirst observed Sep 25, 2025 in this market$355K
- EMULATE INCFirst observed Aug 28, 2025 in this market$293K
- UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE, INC.First observed Sep 23, 2025 in this market$90K
- KAUFFMAN MICHAEL DFirst observed Sep 9, 2025 in this market$86K
- 10X GENOMICS, INC.First observed Jan 7, 2026 in this market$37K
- YECURIS CORPFirst observed May 28, 2026 in this market$16K
THE EMMES COMPANY, LLC had the largest decline in reported obligations
SEATTLE CHILDREN'S HOSPITAL had no reported activity in the latest 12 months
TEMPUS AI, INC was the largest newly observed contractor
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Funding pattern for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services
See how positive obligations were attributed across funding offices in the 12 months ending Jul 27, 2026.
34.3% of positive obligations were attributed to NIH NCI. That represents $604.8M, down $112.9M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- NIH NCI34.3% · $604.8M · down $112.9M
- NATIONAL INSTITUTES OF HEALTH NIAID28.5% · $502.4M · up $126.4M
- OFC OF ACQUISITION AND GRANTS MGMT7.6% · $134.9M · up $72.1M
- NATIONAL INSTITUTES OF HEALTH NCATS5.9% · $104.5M · up $104.1M
- NATIONAL INSTITUTES OF HEALTH NHLBI5.0% · $89.1M · up $2.0M
- All other reported offices18.7% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
NIH NCI
#1Rank unchangedLatest 12 months
$604.8M
34.3% of positive obligations
Versus preceding 12 months
−$112.9M
50 active prime contractors · 148 awards
View office comparison and evidence
Reported obligations decreased 15.7% from $717.7M to $604.8M. The office’s share of positive obligations moved from 41.4% to 34.3%, a change of −7.1 percentage points.
The latest period contains 219 actions across 148 awards and 16 newly active prime contractors. The preceding period contained 94 active prime contractors and 200 awards.
Leading award-level changes
- LEIDOS BIOMEDICAL RESEARCH INC · PIID 75N91024F00011−$370.4M: $384.7M → $14.3M
- LEIDOS BIOMEDICAL RESEARCH INC · PIID 75N91025F00016+$337.9M: $0 → $337.9M
Reported funding office
NATIONAL INSTITUTES OF HEALTH NIAID
#2Rank unchangedLatest 12 months
$502.4M
28.5% of positive obligations
Versus preceding 12 months
+$126.4M
84 active prime contractors · 170 awards
View office comparison and evidence
Reported obligations increased 33.6% from $376.0M to $502.4M. The office’s share of positive obligations moved from 21.7% to 28.5%, a change of +6.8 percentage points.
The latest period contains 319 actions across 170 awards and 20 newly active prime contractors. The preceding period contained 101 active prime contractors and 205 awards.
Leading award-level changes
- LEIDOS BIOMEDICAL RESEARCH INC · PIID 75N91023F00008+$119.4M: −$119.4M → $0
- LEIDOS BIOMEDICAL RESEARCH INC · PIID 75N91025F00014+$87.1M: $0 → $87.1M
Reported funding office
OFC OF ACQUISITION AND GRANTS MGMT
#3Up 4 from #7Latest 12 months
$134.9M
7.6% of positive obligations
Versus preceding 12 months
+$72.1M
1 active prime contractor · 17 awards
View office comparison and evidence
Reported obligations increased 114.8% from $62.8M to $134.9M. The office’s share of positive obligations moved from 3.6% to 7.6%, a change of +4.0 percentage points.
The latest period contains 42 actions across 17 awards. The preceding period contained 2 active prime contractors and 17 awards.
Reported funding office
NATIONAL INSTITUTES OF HEALTH NCATS
#4Up 27 from #31Latest 12 months
$104.5M
5.9% of positive obligations
Versus preceding 12 months
+$104.1M
6 active prime contractors · 12 awards
View office comparison and evidence
Reported obligations increased 27163.6% from $383K to $104.5M. The office’s share of positive obligations moved from 0.020% to 5.9%, a change of +5.9 percentage points.
The latest period contains 13 actions across 12 awards and 3 newly active prime contractors. The preceding period contained 6 active prime contractors and 12 awards.
Reported funding office
NATIONAL INSTITUTES OF HEALTH NHLBI
#5Rank unchangedLatest 12 months
$89.1M
5.0% of positive obligations
Versus preceding 12 months
+$2.0M
48 active prime contractors · 141 awards
View office comparison and evidence
Reported obligations increased 2.3% from $87.1M to $89.1M. The office’s share of positive obligations moved from 5.0% to 5.0%, a change of 0.0 percentage points.
The latest period contains 187 actions across 141 awards and 9 newly active prime contractors. The preceding period contained 50 active prime contractors and 159 awards.
Reported funding office
NATIONAL INSTITUTES OF HEALTH NIDA
#6Rank unchangedLatest 12 months
$79.2M
4.5% of positive obligations
Versus preceding 12 months
−$5.7M
34 active prime contractors · 84 awards
View office comparison and evidence
Reported obligations decreased 6.8% from $85.0M to $79.2M. The office’s share of positive obligations moved from 4.9% to 4.5%, a change of −0.4 percentage points.
The latest period contains 112 actions across 84 awards and 13 newly active prime contractors. The preceding period contained 32 active prime contractors and 95 awards.
Reported funding office
BARDA - ASPR / DAAPPO / BARDA DCMA
#7Down 4 from #3Latest 12 months
$56.7M
3.2% of positive obligations
Versus preceding 12 months
−$44.2M
23 active prime contractors · 33 awards
View office comparison and evidence
Reported obligations decreased 43.8% from $100.9M to $56.7M. The office’s share of positive obligations moved from 5.8% to 3.2%, a change of −2.6 percentage points.
The latest period contains 66 actions across 33 awards and 3 newly active prime contractors. The preceding period contained 31 active prime contractors and 41 awards.
Reported funding office
NATIONAL INSTITUTE OF HEALTH NIEHS
#8Up 1 from #9Latest 12 months
$43.2M
2.5% of positive obligations
Versus preceding 12 months
+$10.6M
6 active prime contractors · 8 awards
View office comparison and evidence
Reported obligations increased 32.4% from $32.6M to $43.2M. The office’s share of positive obligations moved from 1.9% to 2.5%, a change of +0.6 percentage points.
The latest period contains 21 actions across 8 awards and 2 newly active prime contractors. The preceding period contained 7 active prime contractors and 8 awards.
Reported funding office
CDC OFFICE OF ACQUISITION SERVICES
#9Down 5 from #4Latest 12 months
$21.8M
1.2% of positive obligations
Versus preceding 12 months
−$68.6M
45 active prime contractors · 61 awards
View office comparison and evidence
Reported obligations decreased 75.9% from $90.3M to $21.8M. The office’s share of positive obligations moved from 5.2% to 1.2%, a change of −4.0 percentage points.
The latest period contains 72 actions across 61 awards and 13 newly active prime contractors. The preceding period contained 97 active prime contractors and 140 awards.
Reported funding office
NATIONAL INSTITUTES OF HEALTH NICHD
#10Down 2 from #8Latest 12 months
$20.6M
1.2% of positive obligations
Versus preceding 12 months
−$21.7M
14 active prime contractors · 48 awards
View office comparison and evidence
Reported obligations decreased 51.3% from $42.3M to $20.6M. The office’s share of positive obligations moved from 2.4% to 1.2%, a change of −1.3 percentage points.
The latest period contains 71 actions across 48 awards and 3 newly active prime contractors. The preceding period contained 23 active prime contractors and 92 awards.
Reported funding office
FDA OFFICE OF ACQ GRANT SVCS
#11Up 5 from #16Latest 12 months
$20.5M
1.2% of positive obligations
Versus preceding 12 months
+$13.2M
32 active prime contractors · 44 awards
View office comparison and evidence
Reported obligations increased 181.4% from $7.3M to $20.5M. The office’s share of positive obligations moved from 0.42% to 1.2%, a change of +0.7 percentage points.
The latest period contains 54 actions across 44 awards and 20 newly active prime contractors. The preceding period contained 24 active prime contractors and 31 awards.
Reported funding office
NATIONAL INSTITUTE OF HEALTH NIH-OD
#22Down 10 from #12Latest 12 months
$2.4M
0.14% of positive obligations
Versus preceding 12 months
−$15.7M
3 active prime contractors · 6 awards
View office comparison and evidence
Reported obligations decreased 86.7% from $18.1M to $2.4M. The office’s share of positive obligations moved from 1.0% to 0.14%, a change of −0.9 percentage points.
The latest period contains 7 actions across 6 awards and 2 newly active prime contractors. The preceding period contained 3 active prime contractors and 6 awards.
How this work is bought
Reported award structure, competition, pricing, work categories, and contracting channels for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services.
During Jul 28, 2025–Jul 27, 2026, this market recorded $1.8B in positive net award obligations across 497 awards. The leading reported procedure, Negotiated Proposal/Quote, accounted for 81.5% of that positive-obligation base. Awards with a reported parent IDV accounted for 71.3%.
- Leading award type
- 71.3%
- Delivery Order
- Leading reported procedure
- 81.5%
- Negotiated Proposal/Quote
- Reported parent IDV
- 71.3%
- of positive obligations had a reported parent IDV
- Median reported offers
- 2
- 276 of 497 awards reported offers
Same-NAICS comparison
Compared with the NAICS 541715 peer median, parent-IDV obligation share is 9.5 percentage points higher, reported full-and-open obligation share is 61.4 percentage points higher, delivery-order obligation share is 9.5 percentage points higher, and median positive award obligations are 255.9% higher.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 71.3% | 61.8% | +9.5 pts |
| Reported full-and-open obligation share | 82.5% | 21.2% | +61.4 pts |
| Delivery-order obligation share | 71.3% | 61.8% | +9.5 pts |
| Median positive award obligations | $908K | $255K | +255.9% |
Peer cohort and comparison limits
The peer median gives each of the 9 eligible agency markets equal weight. The included agency markets are:
- Department of Agriculture (USDA)
- Department of Commerce (COMMERCE)
- Department of Defense (DOD)
- Department of Homeland Security (DHS)
- Department of the Interior (INTERIOR)
- Department of Transportation (TRANSPORTATION)
- Department of Veterans Affairs (VA)
- Environmental Protection Agency (EPA)
- National Aeronautics and Space Administration (NASA)
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 316 | $1.3B | 71.3% |
| Definitive Contract(D) | 149 | $519.4M | 28.5% |
| Purchase Order(B) | 32 | $2.6M | 0.14% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 315 | $1.3B | 71.3% |
| FSS(C) | 1 | $7K | 0% |
| Not reported | 181 | $522.0M | 28.7% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 221 | $1.2B | 66.6% |
| Multiple Award(M) | 95 | $85.7M | 4.7% |
| Not reported | 181 | $522.0M | 28.7% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Negotiated Proposal/Quote(NP) | 297 | $1.5B | 81.5% |
| Only One Source(SSS) | 72 | $235.7M | 12.9% |
| Subject To Multiple Award Fair Opportunity(MAFO) | 95 | $85.7M | 4.7% |
| Basic Research(BR) | 3 | $9.8M | 0.54% |
| Simplified Acquisition(SP1) | 29 | $3.0M | 0.17% |
| Two Step(TS) | 1 | $2.3M | 0.12% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Full And Open Competition(A) | 340 | $1.5B | 82.5% |
| Not Competed(C) | 63 | $211.8M | 11.6% |
| Full And Open Competition After Exclusion Of Sources(D) | 56 | $79.2M | 4.3% |
| Not Available For Competition(B) | 9 | $23.9M | 1.3% |
| Competed Under SAP(F) | 17 | $1.9M | 0.11% |
| Not Competed Under SAP(G) | 12 | $1.1M | 0.060% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Fair Opportunity Given(FAIR) | 74 | $74.9M | 4.1% |
| Follow-On Action Following Competitive Initial Action(FOO) | 15 | $8.3M | 0.46% |
| Competitive Set Aside(CSA) | 2 | $2.0M | 0.11% |
| Only One Source - Other(ONE) | 2 | $328K | 0.020% |
| Other Statutory Authority(OSA) | 2 | $178K | 0.010% |
| Not reported | 402 | $1.7B | 95.3% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Mobilization, Essential R&d (FAR 6.302-3)(MES) | 38 | $167.3M | 9.2% |
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 23 | $42.7M | 2.4% |
| Authorized By Statute (FAR 6.302-5(A)(2)(I))(OTH) | 11 | $24.5M | 1.4% |
| Unsolicited Research Proposal (FAR 6.302-1(A)(2)(I))(UR) | 1 | $1.2M | 0.060% |
| Follow-On Contract (FAR 6.302-1(A)(2)(Ii/Iii))(FOC) | 1 | $610K | 0.030% |
| SAP Non-Competition (FAR 13)(SP2) | 10 | $440K | 0.020% |
| Not reported | 413 | $1.6B | 87.0% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Cost Plus Fixed Fee(U) | 201 | $1.4B | 75.2% |
| Cost No Fee(S) | 135 | $274.2M | 15.1% |
| Firm Fixed Price(J) | 125 | $98.9M | 5.4% |
| Cost Sharing(T) | 15 | $46.3M | 2.5% |
| Time And Materials(Y) | 15 | $20.1M | 1.1% |
| Labor Hours(Z) | 3 | $5.9M | 0.32% |
| Other reported values | 3 | $5.5M | 0.30% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Health R&d Services; Health Care Services; Applied Research(AN12) | 238 | $1.3B | 70.4% |
| Health R&d Services; Health Care Services; Basic Research(AN11) | 93 | $214.5M | 11.8% |
| Support- Professional: Other(R499) | 32 | $62.7M | 3.4% |
| Health R&d Services; Health Care Services; Experimental Development(AN13) | 16 | $54.0M | 3.0% |
| IT And Telecom - Business Application/Application Development Support Services (Labor)(DA01) | 4 | $36.8M | 2.0% |
| General Science And Technology R&d Services; General Science And Technology; Applied Research(AJ12) | 10 | $34.8M | 1.9% |
| Other reported values | 104 | $136.4M | 7.5% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| National Institutes of Health(7529) | 384 | $1.5B | 84.8% |
| Centers for Medicare and Medicaid Services(7530) | 15 | $134.9M | 7.4% |
| Office of Assistant Secretary for Preparedness and Response(7505) | 12 | $56.7M | 3.1% |
| Centers for Disease Control and Prevention(7523) | 23 | $30.5M | 1.7% |
| Food and Drug Administration(7524) | 25 | $20.9M | 1.1% |
| Office of the Assistant Secretary for Financial Resources(7571) | 8 | $10.7M | 0.59% |
| Other reported values | 30 | $23.0M | 1.3% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Nih Nci(75N910) | 104 | $942.0M | 51.8% |
| National Institutes Of Health Niaid(75N930) | 94 | $293.0M | 16.1% |
| Ofc Of Acquisition And Grants Mgmt(75FCMC) | 15 | $134.9M | 7.4% |
| National Institutes Of Health Nida(75N950) | 46 | $97.4M | 5.3% |
| National Institutes Of Health Nhlbi(75N920) | 62 | $92.0M | 5.1% |
| Barda - Aspr / Daappo / Barda Dcma(75A501) | 12 | $56.7M | 3.1% |
| Other reported values | 164 | $203.9M | 11.2% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 75N91019D00024(7529) | 52 | $853.9M | 46.9% |
| 75FCMC23D0004(7530) | 33 | $161.6M | 8.9% |
| 75N93020D00011(7529) | 2 | $17.7M | 0.97% |
| 75N92021D00001(7529) | 1 | $10.2M | 0.56% |
| 75N96018D00005(7529) | 2 | $9.6M | 0.53% |
| 75N92025D00012(7529) | 2 | $9.5M | 0.52% |
| 75N98026D00018(7529) | 3 | $9.4M | 0.52% |
| 75N93024D00003(7529) | 1 | $8.2M | 0.45% |
| Other reported values | 220 | $217.8M | 12.0% |
| Not reported | 181 | $522.0M | 28.7% |
Exactly matched vehicle usage
- SEER
20 awards · 19 matched parent PIIDs
Evidence: 75N91018D00002, 75N91018D00003, 75N91018D00004, 75N91018D00005, 75N91018D00006, …
$34.3M · 1.9%
- WHI Regional Centers
4 awards · 4 matched parent PIIDs
Evidence: 75N92021D00001, 75N92021D00002, 75N92021D00003, 75N92021D00004
$13.6M · 0.75%
$3.6M · 0.20%
$500K · 0.030%
28 awards matched an unambiguous catalog vehicle PIID. Company membership is not used as evidence of award-channel usage.
Offers, award size, and timing
- Median reported offers
- 2 median
- 276 reported · 221 not reported
- Positive award obligations
- $908K median
- $299K–$2.6M middle 50%
- Reported performance period
- 775 days (~2.1 years) median
- 497 reported · 0 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Jul 27, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Prime contractors for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services
Latest 12-month concentration and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 27 of 233prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 46.3%of positive obligations in the last 12 months
- Leading four prime contractors
- 61.5%of positive obligations in the last 12 months
- Leading eight prime contractors
- 66.9%of positive obligations in the last 12 months
Based on $1.8B in positive obligations during the 12 months ending Jul 27, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Jul 28, 2024–Jul 27, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$823.4M
46.3%
Dollar movement
+$227.2M
vs. prior 12 months
Last 12mo awards
107 awards
168 actions
Historical and award details for LEIDOS BIOMEDICAL RESEARCH INC
- Obligations: prior → latest
- $596.2M → $823.4M
- +38.1%
- Share: prior → latest
- 34.0% → 46.3%
- +12.3 percentage points
- All-period obligations
- $3.7B
- 38.5% of all-period positive obligations · 163 awards
- Recorded activity
- Since Oct 27, 2021
- through Jul 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 107 100 Reported small business 0 0 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$160.4M
9.0%
Dollar movement
+$50.7M
vs. prior 12 months
Last 12mo awards
41 awards
84 actions
Historical and award details for THE MITRE CORPORATION
- Obligations: prior → latest
- $109.7M → $160.4M
- +46.2%
- Share: prior → latest
- 6.3% → 9.0%
- +2.8 percentage points
- All-period obligations
- $288.7M
- 3.0% of all-period positive obligations · 60 awards
- Recorded activity
- Since Sep 27, 2023
- through Jul 13, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 1 Not reported 41 41 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$63.1M
3.5%
Dollar movement
−$5.2M
vs. prior 12 months
Last 12mo awards
14 awards
25 actions
Historical and award details for WESTAT, INC.
- Obligations: prior → latest
- $68.3M → $63.1M
- −7.6%
- Share: prior → latest
- 3.9% → 3.5%
- −0.3 percentage points
- All-period obligations
- $257.3M
- 2.7% of all-period positive obligations · 46 awards
- Recorded activity
- Since Oct 14, 2021
- through Jul 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 2 Not reported 13 25 Reported small business 0 0 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$47.0M
2.6%
Dollar movement
+$365K
vs. prior 12 months
Last 12mo awards
12 awards
16 actions
Historical and award details for TECHNICAL RESOURCES INTERNATIONAL, INC.
- Obligations: prior → latest
- $46.7M → $47.0M
- +0.8%
- Share: prior → latest
- 2.7% → 2.6%
- 0.0 percentage points
- All-period obligations
- $187.2M
- 1.9% of all-period positive obligations · 18 awards
- Recorded activity
- Since Oct 28, 2021
- through Jul 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 2 2 Reported no set-aside 3 3 Not reported 7 7 Reported small business 12 12 All-period set-aside types
- 3 · Total small business
- #5
Last 12mo obligations
$31.8M
1.8%
Dollar movement
−$8.3M
vs. prior 12 months
Last 12mo awards
22 awards
36 actions
Historical and award details for DUKE UNIVERSITY
- Obligations: prior → latest
- $40.1M → $31.8M
- −20.7%
- Share: prior → latest
- 2.3% → 1.8%
- −0.5 percentage points
- All-period obligations
- $193.6M
- 2.0% of all-period positive obligations · 49 awards
- Recorded activity
- Since Oct 12, 2021
- through Jul 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 10 11 Not reported 12 24 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$23.1M
1.3%
Dollar movement
−$1.1M
vs. prior 12 months
Last 12mo awards
8 awards
17 actions
Historical and award details for AMERICAN TYPE CULTURE COLLECTION
- Obligations: prior → latest
- $24.2M → $23.1M
- −4.7%
- Share: prior → latest
- 1.4% → 1.3%
- −0.1 percentage points
- All-period obligations
- $166.2M
- 1.7% of all-period positive obligations · 18 awards
- Recorded activity
- Since Oct 14, 2021
- through May 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 2 Not reported 7 8 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$21.6M
1.2%
Dollar movement
−$4.1M
vs. prior 12 months
Last 12mo awards
28 awards
39 actions
Historical and award details for SRI INTERNATIONAL
- Obligations: prior → latest
- $25.7M → $21.6M
- −16.0%
- Share: prior → latest
- 1.5% → 1.2%
- −0.3 percentage points
- All-period obligations
- $100.2M
- 1.0% of all-period positive obligations · 63 awards
- Recorded activity
- Since Oct 12, 2021
- through Jul 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 2 Not reported 25 26 Reported small business 0 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$18.5M
1.0%
Dollar movement
+$1.6M
vs. prior 12 months
Last 12mo awards
1 award
5 actions
Historical and award details for BATTELLE MEMORIAL INSTITUTE
- Obligations: prior → latest
- $16.9M → $18.5M
- +9.6%
- Share: prior → latest
- 0.96% → 1.0%
- +0.1 percentage points
- All-period obligations
- $35.4M
- 0.37% of all-period positive obligations · 2 awards
- Recorded activity
- Since Mar 16, 2022
- through Jun 25, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$17.2M
0.97%
Dollar movement
−$5.0M
vs. prior 12 months
Last 12mo awards
14 awards
21 actions
Historical and award details for THE JOHNS HOPKINS UNIVERSITY
- Obligations: prior → latest
- $22.2M → $17.2M
- −22.4%
- Share: prior → latest
- 1.3% → 0.97%
- −0.3 percentage points
- All-period obligations
- $77.3M
- 0.80% of all-period positive obligations · 53 awards
- Recorded activity
- Since Oct 13, 2021
- through Jul 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 4 7 Not reported 10 27 Reported small business 0 0 All-period set-aside types
None reported.
- #10
Last 12mo obligations
$17.2M
0.97%
Dollar movement
−$19.6M
vs. prior 12 months
Last 12mo awards
19 awards
25 actions
Historical and award details for THE EMMES COMPANY, LLC
- Obligations: prior → latest
- $36.9M → $17.2M
- −53.3%
- Share: prior → latest
- 2.1% → 0.97%
- −1.1 percentage points
- All-period obligations
- $132.6M
- 1.4% of all-period positive obligations · 69 awards
- Recorded activity
- Since Oct 28, 2021
- through Jul 7, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 2 Not reported 17 29 Reported small business 1 2 All-period set-aside types
- 1 · Total small business
- #11
Last 12mo obligations
$16.7M
0.94%
Dollar movement
−$17.6M
vs. prior 12 months
Last 12mo awards
4 awards
19 actions
Historical and award details for ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
- Obligations: prior → latest
- $34.3M → $16.7M
- −51.3%
- Share: prior → latest
- 2.0% → 0.94%
- −1.0 percentage points
- All-period obligations
- $147.2M
- 1.5% of all-period positive obligations · 5 awards
- Recorded activity
- Since Oct 12, 2021
- through Jul 9, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 4 4 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$16.5M
0.93%
Dollar movement
+$15.2M
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
- Obligations: prior → latest
- $1.3M → $16.5M
- +1166.7%
- Share: prior → latest
- 0.070% → 0.93%
- +0.9 percentage points
- All-period obligations
- $38.0M
- 0.39% of all-period positive obligations · 4 awards
- Recorded activity
- Since May 24, 2022
- through May 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$15.0M
0.84%
Dollar movement
+$15.0M
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for FLOSONICS MEDICAL LLC
- Obligations: prior → latest
- $0 → $15.0M
- Not comparable
- Share: prior → latest
- 0% → 0.84%
- +0.8 percentage points
- All-period obligations
- $15.0M
- 0.16% of all-period positive obligations · 1 award
- Recorded activity
- Since Jun 5, 2026
- through Jun 5, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 0 Not reported 0 0 Reported small business 1 0 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$14.2M
0.80%
Dollar movement
+$5.2M
vs. prior 12 months
Last 12mo awards
2 awards
8 actions
Historical and award details for REVAGENIX INC
- Obligations: prior → latest
- $9.0M → $14.2M
- +57.8%
- Share: prior → latest
- 0.51% → 0.80%
- +0.3 percentage points
- All-period obligations
- $49.4M
- 0.51% of all-period positive obligations · 2 awards
- Recorded activity
- Since Oct 14, 2021
- through Jul 10, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 2 Not reported 0 0 Reported small business 2 2 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$13.7M
0.77%
Dollar movement
−$1.6M
vs. prior 12 months
Last 12mo awards
4 awards
6 actions
Historical and award details for FRED HUTCHINSON CANCER CENTER
- Obligations: prior → latest
- $15.3M → $13.7M
- −10.3%
- Share: prior → latest
- 0.87% → 0.77%
- −0.1 percentage points
- All-period obligations
- $57.2M
- 0.59% of all-period positive obligations · 10 awards
- Recorded activity
- Since Jul 12, 2022
- through Jul 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 1 Not reported 4 5 Reported small business 0 0 All-period set-aside types
None reported.
Recompete watch for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services
Investigate potential recompetes surfaced by near-term end dates, award value, and recent contract changes.
SOCIAL & SCIENTIFIC SYSTEMS, INC.
THE SISTER STUDY: TASK ORDER 01 - CORE ACTIVITIES
The reported potential end date is Aug 22, 2026. Current award value is 100.0% of reported potential value ($56.3M of $56.3M).
Performance period
99.1%
Current award value as a share of potential value
100.0%
Supporting data
Reported performance starts Aug 22, 2018.
No later potential end date is reported; current and potential end dates are both Aug 22, 2026.
$56.3M is obligated against $56.3M in current reported award value (100.0%).
Reported potential end dates: Aug 22, 2023 → Aug 22, 2024 → Aug 22, 2025 → Aug 22, 2026.
Obligations are compared with current reported award value, not treated as a contract ceiling.
SAFESOURCE DIRECT LLC
EO 14398; INDUSTRIAL BASE EXPANSION OF NITRILE GLOVES MANUFACTURING
The reported potential end date is Dec 15, 2026. Current award value is 100.0% of reported potential value ($144.8M of $144.8M).
Performance period
88.0%
Current award value as a share of potential value
100.0%
Supporting data
Reported performance starts Sep 30, 2023.
No later potential end date is reported; current and potential end dates are both Dec 15, 2026.
$144.8M is obligated against $144.8M in current reported award value (100.0%).
Reported potential end dates: Sep 29, 2025 → Jun 30, 2026 → Dec 15, 2026.
Obligations are compared with current reported award value, not treated as a contract ceiling.
LEIDOS BIOMEDICAL RESEARCH INC
EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET)
The reported potential end date is Oct 31, 2026. Current award value is 100.0% of reported potential value ($143.6M of $143.6M).
Performance period
95.4%
Current award value as a share of potential value
100.0%
Supporting data
Reported performance starts Feb 10, 2021.
No later potential end date is reported; current and potential end dates are both Oct 31, 2026.
$143.6M is obligated against $143.6M in current reported award value (100.0%).
Reported potential end dates: Feb 10, 2026 → Oct 31, 2026.
Obligations are compared with current reported award value, not treated as a contract ceiling.
ASCEND PERFORMANCE MATERIALS TEXAS INC
DOMESTIC INDUSTRIAL BASE EXPANSION OF KEY CHEMICALS FOR ACRYLONITRILE BUTADIENE RUBBER (NBR)
The reported potential end date is Sep 26, 2026. Current award value is 100.0% of reported potential value ($87.7M of $87.7M).
Performance period
94.2%
Current award value as a share of potential value
100.0%
Supporting data
Reported performance starts Nov 1, 2023.
No later potential end date is reported; current and potential end dates are both Sep 26, 2026.
$87.7M is obligated against $87.7M in current reported award value (100.0%).
Obligations are compared with current reported award value, not treated as a contract ceiling.
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU
The reported potential end date is Sep 9, 2026. Current award value is 62.0% of reported potential value ($74.6M of $120.2M).
Performance period
98.3%
Current award value as a share of potential value
62.0%
Supporting data
Reported performance starts Sep 10, 2019.
No later potential end date is reported; current and potential end dates are both Sep 9, 2026.
$74.6M is obligated against $74.6M in current reported award value (100.0%).
Reported potential end dates: Sep 29, 2022 → May 14, 2023 → Sep 9, 2024 → Sep 29, 2024 → Sep 9, 2025 → Sep 9, 2026.
Obligations are compared with current reported award value, not treated as a contract ceiling.
BIOQUAL, INC.
ANIMAL CARE AND LABORATORY SUPPORT SERVICES TO THE VACCINE RESEARCH CENTER
The reported potential end date is Sep 27, 2026. Current award value is 57.5% of reported potential value ($60.7M of $105.5M).
Performance period
97.6%
Current award value as a share of potential value
57.5%
Supporting data
Reported performance starts Sep 28, 2019.
No later potential end date is reported; current and potential end dates are both Sep 27, 2026.
$60.7M is obligated against $60.7M in current reported award value (100.0%).
Obligations are compared with current reported award value, not treated as a contract ceiling.
These are research leads, not confirmed recompetes. USAspending records through Jul 27, 2026; reported dates and values can change through later modifications.
Award activity for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$271.0M
LEIDOS BIOMEDICAL RESEARCH INC
NIH NCI
NCI OPERATIONAL TASK ORDER, FY26-FY27
Why it stands out
This award grew while spending attributed to its office declined.
The modification added $271.0M while office-attributed obligations fell $112.9M overall.
- Award net obligations
- $337.9M
- Share of 12-month positive obligations
- 15.2%
Supporting data
- Prime contractor
- #1 · 46.3% share
- +12.3 percentage points · $227.2M net increase; action exceeded it by $43.8M
- Funding office
- #1 · 34.3% attributed share
- $112.9M net decline despite this positive action
This action
+$102.8M
LEIDOS BIOMEDICAL RESEARCH INC
NATIONAL INSTITUTES OF HEALTH NCATS
ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
Why it stands out
The award grew alongside stronger office-attributed spending.
The modification added $102.8M while office-attributed obligations rose $104.1M overall.
- Award net obligations
- $141.7M
- Share of 12-month positive obligations
- 5.8%
Supporting data
- Funding office
- #4 · 5.9% attributed share
- up 27 ranks · +5.9 percentage points · $104.1M net increase; action accounted for 98.7%
This action
+$57.1M
LEIDOS BIOMEDICAL RESEARCH INC
NATIONAL INSTITUTES OF HEALTH NIAID
NIAID DCR FY26-27 OPERATIONAL TASK ORDER
Why it stands out
The award grew alongside stronger office-attributed spending.
The modification added $57.1M while office-attributed obligations rose $126.4M overall.
- Award net obligations
- $77.6M
- Share of 12-month positive obligations
- 3.2%
Supporting data
- Funding office
- #2 · 28.5% attributed share
- +6.8 percentage points · $126.4M net increase; action accounted for 45.2%
This action
+$16.5M
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
BARDA - ASPR / DAAPPO / BARDA DCMA
ADD ADDITIONAL FUNDING TO THE BASE PERIOD; UPDATE COA THRESHOLD TO $350,000; ADD BERYL VOIGT AS ALTERNATE COR; UPDATE FAR/HHSAR CLAUSES PER EXECUTIVE ORDERS AND REVOLUTIONARY FAR/HHSAR OVERHAUL (RFO); UPDATE SOW AND CONTRACT MILESTONES AND DELIVERABL
Why it stands out
This award grew while spending attributed to its office declined.
The modification added $16.5M while office-attributed obligations fell $44.2M overall.
- Award net obligations
- $37.6M
- Share of 12-month positive obligations
- 0.93%
Supporting data
- Prime contractor
- #12 · 0.93% share
- up 134 ranks · +0.9 percentage points · $15.2M net increase; action exceeded it by $1.3M
- Funding office
- #7 · 3.2% attributed share
- $44.2M net decline despite this positive action
This action
+$47.8M
WESTAT, INC.
NATIONAL INSTITUTES OF HEALTH NIDA
POPULATION ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY PERIOD OF PERFORMANCE: 02/01/2024 - 11/30/2030.
Why it stands out
This award grew while spending attributed to its office declined.
The modification added $47.8M while office-attributed obligations fell $5.7M overall.
- Award net obligations
- $85.5M
- Share of 12-month positive obligations
- 2.7%
Supporting data
- Prime contractor
- #3 · 3.5% share
- $5.2M net decline despite this positive action
- Funding office
- #6 · 4.5% attributed share
- $5.7M net decline despite this positive action
This action
+$13.4M
THE MITRE CORPORATION
OFC OF ACQUISITION AND GRANTS MGMT
MARKETPLACE PLAN MANAGEMENT COMPLIANCE REVIEWS EOI::EXECUTIVE ORDER 14222 IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE::EOI BILATERAL MODIFICATION TO DESCOPE
Why it stands out
The award grew alongside stronger contractor activity.
The modification added $13.4M while contractor obligations rose $50.7M overall.
- Award net obligations
- $34.8M
- Share of 12-month positive obligations
- 0.75%
Supporting data
- Prime contractor
- #2 · 9.0% share
- +2.8 percentage points · $50.7M net increase; action accounted for 26.4%
- Funding office
- #3 · 7.6% attributed share
- up 4 ranks · +4.0 percentage points · $72.1M net increase; action accounted for 18.5%
View recent award activity by date (10)
- Action−$18KAward net obligations$1.9M
- Action−$3KAward net obligations$37K
- Action−$7KAward net obligations$13K
- Action+$462KAward net obligations$2.7M
- Action+$2.7MAward net obligations$2.7M
- Action+$2.5MAward net obligations$14.6M
- Action+$1.4MAward net obligations$4.6M
- Action+$657KAward net obligations$5.4M
- Action+$20KAward net obligations$20K
- Action−$190Award net obligations$10.2M
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Reported obligations include contract actions from October 1, 2021 through July 27, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.
Review data methodology